rethinkTHC Search
Menu
Study breakdown

Occupational medicine guideline says cannabis is not recommended for common workplace injuries and conditions

ReviewStrong evidence
The takeaway

An ACOEM guideline found no quality evidence supporting cannabis for common work-related pain conditions, documented many adverse effects, and recommended against use in safety-sensitive positions.

Occupational medicine physicians, employers, workers' compensation professionals, safety officers.

No quality evidence of efficacy for back pain, neuropathic pain, or other common work conditions

What the researchers found

Some evidence for MS spasticity, but no quality evidence for back pain, radiculopathy, neuropathic pain, or other common work-related pain. Quality evidence supports lack of efficacy for postoperative pain. Documented adverse effects include cancers, cardiovascular diseases, psychotic disorders, and safety risks.

Why it matters

As legalization expands, employers face pressure to allow cannabis. This provides evidence-based grounds for workplace policies, particularly for safety-sensitive positions.

The numbers in context

Efficacy evidence: some for MS spasticity only. No quality evidence for: back pain, radiculopathy, neuropathic pain. Evidence against: postoperative pain. Harms: cancers, cardiovascular, psychotic disorders, safety risks.

How the study worked

Evidence-based guideline developed using ACOEM methodology, systematically reviewing evidence on cannabis efficacy and safety for work-related conditions.

What this study cannot tell us

Guidelines reflect evidence at publication; new trials may change recommendations. May reflect conservative occupational medicine perspective.

How to read the evidence

Systematic evidence-based guideline using ACOEM methodology, a high standard for occupational medicine recommendations.

When this study was published

Published in 2025.

The bigger picture

The gap between public perception of cannabis as a pain treatment and the evidence base has direct workplace safety implications.

Questions still open

  • Will ongoing trials change the chronic pain picture? How should employers handle workers using cannabis for other conditions?

Common questions

Does cannabis work for workplace injury pain?
According to this guideline, no quality evidence supports cannabis for common work-related conditions. Only MS spasticity has some supporting evidence.
Can workers use cannabis in safety-sensitive jobs?
The guideline recommends against it, citing documented adverse effects on cognition, reaction time, and safety.

Read the original research

Cannabis.

Journal of occupational and environmental medicine, 67(12), e860-e871

Citation

Feinberg, Steven D; Aronoff, Gerald M; Ausfahl, James; Bruns, Daniel; Darnall, Beth D; Goldberg, Robert L; Haldeman, Scott; Lessenger, James E; Mandel, Steven; Mayer, Tom G; Navani, Annu H; Osbahr, Albert J; Warren, Pamela A; Winters, Thomas H; Harris, Jeffrey S; Hegmann, Kurt T. (2025). Cannabis.. Journal of occupational and environmental medicine, 67(12), e860-e871. https://doi.org/10.1097/JOM.0000000000003548

Explore the wider topic